MedTrace Logo

Immune Response in Patients With Hepatitis B and C Infection

NCT02275221 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2024-01-12

No results posted yet for this study

Summary

Using peripheral blood mononuclear cells (PBMC) and serum collection from HBV and HCV infected patients in a number of different immunological assays, the investigators hope to identify any changes in the number and function of these immune cells and to investigate how these changes contribute to viral persistence and disease progression.

Conditions

Sponsors & Collaborators

  • Foundation for Liver Research

    collaborator OTHER

  • Mid and South Essex NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Gavin Wright, MBBS MRCP · Basildon and Thurrock University Hospitals NHS FT

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02275221 on ClinicalTrials.gov